Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Chordoma × Protons × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 3 Prostatic Neoplasms 2 Glioma 2 Glioblastoma 2 Squamous Cell Carcinoma of Head and Neck 1 Resectable Lung Non-Small Cell Carcinoma 1 Radiation Injuries 1 Pancreatic Neoplasms 1 Oligodendroglioma 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Lung Neoplasms 1 Gastroesophageal Junction Adenocarcinoma 1 Frailty 1 Chordoma 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Neoplasms 1 Breast Carcinoma In Situ 1 Astrocytoma 1

Interventions

Nivolumab 3 palbociclib 2 Ipilimumab 2 Imatinib Mesylate 2 relatlimab 1 pembrolizumab 1 camrelizumab 1 apatinib 1 Specimen Handling 1 Radiotherapy 1 Radiation 1 Protons 1 Proton Therapy 1 Pemetrexed 1 Magnetic Resonance Spectroscopy 1 Immunoglobulin G 1 Disulfides 1 Cetuximab 1 CTLA-4 Antigen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01811394 2023-12-06

ISAC

Heidelberg University

Phase 2 Unknown

Chordoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡